Heba Omar Ahmed Omar <br/><br/>
Effect of recombinant activated factor VII (rFVIIa) on intraoperative blood loss during pediatric brain surgery :   A clinical and thromboelastographic study /  
 تأثير العامل السابع معاد الإتحاد النشط على فقدان الدم أثناء العملية في جراحة المخ للأطفال 
Heba Omar Ahmed Omar ; Supervised Iman Riad M. Abdelaal , Enas M. Ghareeb Elshazly , Mohamed Ibrahem Sonbati 
 - Cairo :   Heba Omar Ahmed Omar ,   2010 
 - 158 P. :   charts ;   25cm 
<br/><br/>Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Anaesthesia 
<br/><br/> There is a clinical need for one or more new hemostatic agents to supplement a help in controlling bleeding in pediatric brain tumor, which cannot be controlled by surgical intervention, local hemostatic agents and transfusion of blood products. Recombinant activated factor VII has been approved by the U.S Food and Drug Administration (FDA) for nearly a decade for the prevention and treatment of bleeding episodes in hemophilic patients with inhibitors to coagulation factor VIII or factor IX 
<br/><br/>
<br/><br/><label>Subjects--Index Terms: </label>Coagulopathy  Hemostasis  RFVIIa